Featured News
Traverse Biosciences Executes Exclusive, Worldwide License Agreement
Mar 16 2015
NEW YORK, NY
Traverse Biosciences, founded by Joseph Scaduto - one of the Center for Biotechnology's first BioEntrepreneurs-in-Residence, annou
Learn MoreMillennial Materials and Devices Presenting at NY Business Plan Competition FinalsApr 8 2015
Gaurav Lalwani, PhD, Biomedical Engineering department at Stony brook University and Center for Biotechnology Fundamentals Program
Learn MoreNew Mathematical Model May Improve Drug Discovery - Study Co-Authored by CFB's Dr. Eleanor AllenApr 22 2015
A new mathematical model that uses drug-target kinetics to predict how drugs work in vivo may provide a foundation to improve drug
Learn More-
7 Dx firms to share $249M from NIH for COVID-19 testingAugust 7, 2020
Seven companies were chosen by the NIH to receive funding for new technologies to boost their testing capacities.
Learn More -
Update: NIH Rapid Acceleration of Diagnostics (RADx) ProgramsJuly 24, 2020
Scientists and inventors with a COVID-19 rapid testing technology: RADx Tech initiative challenge awarding shares of up to $500 million over all phases of development.
Learn More -
Webinar Recording: How BARDA is Investing $2B to Combat COVID-19June 17, 2020
Catch up on the recent webinar with BARDA detailing how the agency in investing to company COVID-19.
Learn More
Upcoming Events
24
Mar
Immuno-Oncology 360° Summit
The Center for Biotechnology is a proud supporter of the 11th Annual Immuno-Oncology 360° Summit. This year's event will highlight the latest advancements and data [...]